While early detection and treatment remain crucial, we're also witnessing a remarkable shift in how we understand and approach breast cancer risk, particularly when it comes to hereditary forms.
Hereditary Breast Cancer: A Complex Landscape
Hereditary breast cancer accounts for roughly 5-10% of all cases, often linked to mutations in genes like BRCA1 and BRCA2. However, the genetic landscape of hereditary breast cancer is vast and complex. Numerous other genes can contribute to increased risk, and identifying these mutations has traditionally been a challenging and time-consuming process.
Gene by Gene Exome Sequencing: Empowering Proactive Health Management
Our exome sequencing is revolutionary technology, transforming the way hereditary cancer risk is assessed. By analyzing the protein-coding regions of the genome (the exome), a wide array of genetic mutations associated with breast cancer and other hereditary cancers can be identified. We know turn around times for results are important, our exome sequencing is efficient and cost effective.
Benefits of Exome Sequencing:
- Comprehensive: Exome sequencing goes beyond BRCA1 and BRCA2, casting a wider net to identify mutations in a multitude of genes linked to breast cancer susceptibility.
- Efficient: Instead of testing for specific genes one by one, exome sequencing provides a comprehensive genetic profile in a single test.
- Personalized Risk Assessment: Identifying genetic mutations enables more accurate risk assessment and personalized cancer prevention strategies.
- Empowerment: Understanding one's genetic risk empowers individuals to make informed decisions about their health and take proactive steps toward early detection and prevention.
- Family Benefit: Genetic testing results can also provide valuable information for family members, potentially identifying those at increased risk and guiding their healthcare decisions.
Exome Sequencing: The fight against hereditary breast cancer
During Breast Cancer Awareness Month, let's celebrate the advancements in genetic testing and recognize the power of exome sequencing in the fight against hereditary breast cancer. This innovative technology provides a crucial tool for early detection, risk assessment, and personalized prevention strategies, empowering individuals and families to take control of their health and potentially save lives.
Early detection and awareness are key in the fight against breast cancer.
Gene by Gene
Company News & Press Releases
Gene By Gene is a world leader in genetic testing services with over 20 years of experience. Our laboratory holds accreditation from multiple agencies, including CAP, CLIA, California Department of Public Health, and AABB. With a cutting-edge laboratory and highly trained team of experts, we are committed to excellence in the field of genetic analysis.
.png)
